Abstract
Patients’ beliefs about their health (and illness), medications and healthcare they receive are important determinants of whether or not they accept recommended treatments; influence their coping responses in relation to their illness; make them adhere to recommended therapy and ultimately affect health outcomes. Incorporation of patients’ preferences for therapy should now be considered an integral part of the decision-making process.
This gradual shift in health-care practice from paternalistic to shared-decision making, whereby there is a two-way exchange of information between the patient and healthcare provider and both are involved in the treatment decision, requires a reasonable level of understanding and knowledge of the condition and its treatment by the patient. However, patients with atrial fibrillation (AF) often have poor knowledge about their condition and the benefits and risks of AF and AF treatments. Physicians and other healthcare providers may have doubts over a patient’s ability to adhere to certain treatment regimens, particularly oral anticoagulation, due in part to the lack of patient knowledge, and this may be an important determinant of whether such treatments are even considered as therapeutic options. Further, patients often hold misconceptions about AF and treatment options, which may act as barriers to their acceptance of the condition and adherence to therapy.
This review will summarise the literature on the knowledge of patients about AF and its management, how patients’ values and preferences can impact on their treatment choices, the ideal components of patient education, the impact of educational interventions on patients’ knowledge and perceptions of AF, and where appropriate highlight specific issues facing lone AF patients.
Keywords: Atrial fibrillation, patients, knowledge, preferences, education.
Current Pharmaceutical Design
Title:Best Practice for Atrial Fibrillation Patient Education
Volume: 21 Issue: 5
Author(s): Deirdre A. Lane, Rachel V. Barker and Gregory Y.H. Lip
Affiliation:
Keywords: Atrial fibrillation, patients, knowledge, preferences, education.
Abstract: Patients’ beliefs about their health (and illness), medications and healthcare they receive are important determinants of whether or not they accept recommended treatments; influence their coping responses in relation to their illness; make them adhere to recommended therapy and ultimately affect health outcomes. Incorporation of patients’ preferences for therapy should now be considered an integral part of the decision-making process.
This gradual shift in health-care practice from paternalistic to shared-decision making, whereby there is a two-way exchange of information between the patient and healthcare provider and both are involved in the treatment decision, requires a reasonable level of understanding and knowledge of the condition and its treatment by the patient. However, patients with atrial fibrillation (AF) often have poor knowledge about their condition and the benefits and risks of AF and AF treatments. Physicians and other healthcare providers may have doubts over a patient’s ability to adhere to certain treatment regimens, particularly oral anticoagulation, due in part to the lack of patient knowledge, and this may be an important determinant of whether such treatments are even considered as therapeutic options. Further, patients often hold misconceptions about AF and treatment options, which may act as barriers to their acceptance of the condition and adherence to therapy.
This review will summarise the literature on the knowledge of patients about AF and its management, how patients’ values and preferences can impact on their treatment choices, the ideal components of patient education, the impact of educational interventions on patients’ knowledge and perceptions of AF, and where appropriate highlight specific issues facing lone AF patients.
Export Options
About this article
Cite this article as:
A. Lane Deirdre, V. Barker Rachel and Y.H. Lip Gregory, Best Practice for Atrial Fibrillation Patient Education, Current Pharmaceutical Design 2015; 21 (5) . https://dx.doi.org/10.2174/1381612820666140825125715
DOI https://dx.doi.org/10.2174/1381612820666140825125715 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
New Approaches to Develop Anti-Staphylococcal Agents
Current Medicinal Chemistry - Anti-Infective Agents Secondary Stroke Prevention in Patients with Cryptogenic Stroke and Patent Foramen Ovale
Vascular Disease Prevention (Discontinued) Editorial: “Ah, Wherefore with Infection Should he Live?”: Microbial Virulence Factors in Diabetic Foot Ulceration
Current Vascular Pharmacology Cardiovascular Disease in Juvenile Idiopathic Arthritis
Current Vascular Pharmacology Nursing Assessment, Education, and Care of Extremely Premature Neonates with Patent Ductus Arteriosus
Current Pediatric Reviews Protective Effects of Astaxanthin on Nephrotoxicity in Rats with Induced Renovascular Occlusion
Combinatorial Chemistry & High Throughput Screening Peculiarities of the Clinical Course of Oxidative Protein and Lipid Modification in Children with Acute Rheumatic Fever
Endocrine, Metabolic & Immune Disorders - Drug Targets Vaccine Therapy for P. acnes-Associated Diseases
Infectious Disorders - Drug Targets Strategies for Antimicrobial Drug Delivery to Biofilm
Current Pharmaceutical Design Structural Insights into Chitinolytic Enzymes and Inhibition Mechanisms of Selective Inhibitors
Current Pharmaceutical Design Human Heart Failure: A Proteomics Perspective
Current Proteomics In Vitro Synergistic Action of Certain Combinations of Gentamicin and Essential Oils
Current Medicinal Chemistry Production of Fibrinolytic Protease from a Halobacterium <i>Bacillus licheniformis</i> VITLMS Isolated from Marine Sponges of Rameshwaram Coast, India
Current Bioactive Compounds Diagnostic and Therapeutic Nanoparticles in Cardiovascular Diseases
Current Pharmaceutical Design Infection and Anemia
Infectious Disorders - Drug Targets The Rise of Carbapenem-Resistant Acinetobacter baumannii
Current Pharmaceutical Design Inflammatory Syndrome in Chronic Kidney Disease: Pathogenesis and Influence on Outcomes
Inflammation & Allergy - Drug Targets (Discontinued) Macrophage Heterogeneity: Relevance and Functional Implications in Atherosclerosis
Current Vascular Pharmacology Perioperative Management of Patients with Down Syndrome
Current Pediatric Reviews ARC - Augmented Renal Clearance
Current Pharmaceutical Biotechnology